Medical person holding a bottle labeled as vaccine cancer. Cancer
| 3 min read
The National Cancer Institute and Foundation for the NIH are seeking $200 million to support clinical trials, develop new vaccine platforms, and build a shared data resource.
The weekly rundown imageRegulatory & Industry
| 4 min read
FDA approvals, trial updates, and more led the news this week.
A light blue DNA strand with tiny pink and blue dots on itRare & Genetic Diseases
| 3 min read
Patients could finally have a therapy available if the repurposed drug is successful. The trial protocol is under review with the Italian Medicines Agency.
The photo of the large intestine on a woman's body against a gray background.Immunology
| 4 min read
What began with a patient's search for relief from ulcerative colitis has become a biotech's effort to turn a botanical discovery into a drug.
Glass-etched cryo-electron miscroscopy-based representation of the TNKS2 enzyme.Cancer
| 2 min read
Cancer researchers have attempted to target the WNT pathway for decades without success due to severe toxicity issues. A new paper could solve that problem.

News

A scientist with a blue-gloved hand holds a beaker with psilocybin mushrooms and faded colors on top.
| 3 min read
DDN Weekly Rundown text in blue on a blue and white background
| 4 min read
Colorful DNA strands on black background.
| 3 min read
3D rendering of cells and DNA on a blue background.
| 3 min read
A lab hallway with computing equipment on the left and white lines on a black wall to the right.
| 5 min read
DDN Weekly Rundown text in blue and white on a dark blue background
| 4 min read

Cancer Research News

Glowing patient-derived tumor organoid connected to a data network, representing organoid screening data.
Samsung Biologics' Seahee Kim explains where patient-derived organoid data earn regulatory weight and where they still fall short
Illustration of a dendritic cell presenting peptide-bearing molecules to two T cells, the priming step behind a WT1 cancer vaccine in AML.
A Phase 3 survival result tests whether antigen choice and disease setting explain earlier cancer vaccine setbacks

Editor's Pick

An illustration of cells with orange nuclei and transparent cytoplasm
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
An illustration of bone marrow containing immune and hematopoietic stem cells
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation. 

Multimedia

A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
Blue microscopic illustration of spherical cells with textured surfaces against a dark background.
Explore how longitudinal single-cell profiling of whole blood can reveal immune signatures associated with CAR T cell therapy-related neurotoxicity.